Dec 1, 2021, 15:17 PM by

RefleXion Medical, Inc., has been granted FDA Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat multiple moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.

Dec 1, 2021, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES—Tom Messina has worked in various roles for Johnson & Johnson dating back to 1999 and is currently an IT Director in J&J’s Pharmaceutical R&D division, Janssen. BioTeam had a chance to speak with Tom recently to appreciate how J&J is leveraging cloud compute and storage resources to maximize innovation and growth while controlling costs.

Nov 30, 2021, 01:00 AM by User Not Found

Bio-IT World | Illumina powers the Canadian COVID-19 Genomics Network, organ-on-a-chip explores infectious disease, and cell analysis acquisitions. Plus new products from PerkinElmer, Bio-Rad, Roswell Biotechnologies, Genialis, and more.

Nov 24, 2021, 13:46 PM by

Nov 24, 2021, 13:46 PM by

The next phase of market growth is likely to be driven by rising demand for personalized medicine, technological advancements, favourable funding environment, growing incidence of cancer & genetic disorders.

Nov 24, 2021, 13:46 PM by

Innovation experts Linda Kasim, Imran Haq and Anca Ciobanu share predictions for innovation in life sciences for the year ahead

Nov 24, 2021, 13:46 PM by

Nov 24, 2021, 13:46 PM by

Nov 24, 2021, 13:46 PM by

InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants

Nov 24, 2021, 13:46 PM by

Stilla Technologies, the multiplex digital PCR company, has secured more than €31 million in new financing, adding Casdin Capital and the European Investment Bank (EIB) in addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management (Luxembourg) S.à r.l., LBO France, BNP Paribas Développement, and Eurazeo.

Nov 24, 2021, 13:46 PM by

Applied BioMath, the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), was listed as one of the top ten biosimulation solution companies for 2021 by Pharma Tech Outlook.

Nov 23, 2021, 01:00 AM by User Not Found

Bio-IT World | Genomics and artificial intelligence (AI) are key to this quest and at-scale advancement of personalized medicine. Both, however, require liquid data and modern data infrastructure that re-imagines the role of data and how it is used.

Nov 22, 2021, 01:00 AM by User Not Found

Bio-IT World | Evidence has been mounting for decades that what men eat can lower or raise their risk of prostate cancer—including aggressive forms of the disease that can be lethal. But that’s only part of the story.

Nov 19, 2021, 19:34 PM by

In a study that builds on earlier research that identified macrophages as essential to regeneration in the axolotl, a highly regenerative salamander, James Godwin, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, has identified the source of these critical white blood cells as the liver. By giving scientists a place to look for pro-regenerative macrophages in humans, the discovery brings science a step closer to being able to regenerate tissues and organs lost to injury or disease in humans.

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Watson-Marlow Fluid Technology Group announces it has been named Most Innovative Pharma Fluid Management Solutions Provider 2021 at the Global Health and Pharma Healthcare and Pharmaceutical Awards.

Nov 19, 2021, 19:34 PM by

Anju Software has announced that Steve Rosenberg, an industry leader and innovator in developing and deploying patient-centric clinical trial technologies, has joined the company's Board of Directors. Rosenberg also formerly led Oracle's clinical software business.

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Singapore-based viral vector CDMO CellVec announces today that it has been selected as the manufacturer of choice for Australian cell therapy immuno-oncology company Carina Biotech, undertaking the production of GMP-compliant lentivirus constructs for its LGR5 CAR-T. The partnership is slated to advance clinical trials for a treatment designed for patients with advanced colorectal (bowel) cancer.